BioSpace News Archive

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that David Domzalski, President and Chief Executive Officer, and Dr. Iain Stuart, Chief Scientific Officer, will present at the HC Wainwright & Co. Global Investment Conference on May 25, 2022.

electroCore, Inc. will be presenting at the H.C. Wainwright Global Investment Conference and LD Micro Invitational Conference.

DENTSPLY SIRONA Inc. received written notification from The NASDAQ Stock Market on May 12, 2022 that the Company is no longer in compliance with the Nasdaq Listing Rules since the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2022.

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, announced strategic actions to focus resources on its lead clinical programs.

US Radiology Specialists, Inc., one of the nation’s premier physician-owned radiology companies, announced that it is partnering with Volpara Health to implement the latest breast density assessment, mammography reporting, and patient communication software at Charlotte Radiology.

BioVaxys Technology Corp. (CSE: BIOV; FRA: 5LB; OTCQB: BVAXF) (“BioVaxys” or “Company”), announced today that Hospices Civils de Lyon, France (“HCL”) has agreed to serve as a clinical study site for the Phase I study of BVX-0918, the Company’s autologous haptenized tumor cell vaccine for late-stage ovarian cancer.

Seelos Therapeutics, Inc. (Nasdaq: SEEL), today announced it has received a Notice of Allowance for U.S. patent application number 16/833,515 from the United States Patent and Trademark Office (USPTO) covering SLS-007 titled: “Structure-Based Peptide Inhibitors of Alpha-Synuclein Aggregation”.

Mozart Therapeutics , a leading developer of CD8 Treg modulators in autoimmune and inflammatory disease, today announced it will present at Digestive Disease Week ® (DDW) taking place May 21-24, 2022 in San Diego, CA and virtually.

Bavarian Nordic A/S announced that the U.S. Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised the first options under the contract to supply a freeze-dried version of JYNNEOS® smallpox vaccine, thus allowing for the first doses of this version to be manufactured and invoiced in 2023 and 2024.

Albany NY, United States: Transparency Market Research has published a new report titled, ‘Dental Implants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.